SuperworthCryo Cell International shares outstanding CCEL
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Aug 31, 2026
- 8.1M
- On a year earlier
- −0.1%
- fewer shares
Cryo Cell International had 8.1M diluted shares outstanding on average in Q3 FY26, the quarter to Aug 31, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 8.1M | −0% |
| FY2024 | 8.1M | −3% |
| FY2023 | 8.3M | −3% |
| FY2022 | 8.5M | −1% |
| FY2021 | 8.6M | +5% |
| FY2020 | 8.1M | −3% |
| FY2019 | 8.4M | +7% |
| FY2018 | 7.8M | +2% |
| FY2017 | 7.6M | +12% |
| FY2016 | 6.8M | −25% |
| FY2015 | 9.1M | −7% |
| FY2014 | 9.7M | −9% |
| FY2013 | 10.8M | −4% |
| FY2012 | 11.3M | −5% |
| FY2011 | 11.8M | −0% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 8.1M | −0% | |
| Q2 FY26 | 8.1M | −1% | |
| Q1 FY26 | 8.1M | −2% | |
| Q4 FY25 | 8.1M | −0% | |
| Q3 FY25 | 8.1M | −1% | |
| Q2 FY25 | 8.1M | −1% | |
| Q1 FY25 | 8.2M | −2% | |
| Q4 FY24 | 8.1M | −3% | |
| Q3 FY24 | 8.2M | −2% | |
| Q2 FY24 | 8.2M | −1% | |
| Q1 FY24 | 8.3M | −2% | |
| Q4 FY23 | 8.3M | −3% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Cryo Cell International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.